| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 5.2% | $3,359,664 | 1,454,400 | Highbridge Capital Management, LLC | 30 Jun 2025 | |||
| CVI Investments, Inc. | 4.9% | -10% | $3,225,404 | -$239,596 | 1,396,279 | -6.9% | CVI Investments, Inc. | 30 Jun 2025 |
| Praetorian PR LLC | 3.4% | -54% | $2,127,972 | -$1,700,160 | 921,200 | -44% | Kupperman Harris | 30 Jun 2025 |
As of 31 Dec 2025, 73 institutional investors reported holding 5,083,640 shares of Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB). This represents 18% of the company’s total 27,969,231 outstanding shares.
The largest institutional shareholders of Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) together control 17% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 4.3% | 1,212,100 | +2.1% | 0% | $1,890,877 |
| VANGUARD GROUP INC | 3.4% | 957,846 | +9.3% | 0% | $1,494,240 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.6% | 441,650 | -5.9% | 0% | $689,170 |
| STATE STREET CORP | 1.2% | 347,259 | +22% | 0% | $541,724 |
| Dauntless Investment Group, LLC | 1.1% | 304,922 | 1.9% | $475,678 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.9% | 250,910 | +60% | 0% | $391,419 |
| RAYMOND JAMES FINANCIAL INC | 0.75% | 210,678 | -22% | 0% | $328,658 |
| NORTHERN TRUST CORP | 0.63% | 175,649 | -7.1% | 0% | $274,012 |
| MORGAN STANLEY | 0.44% | 122,512 | +62% | 0% | $191,120 |
| Westside Investment Management, Inc. | 0.39% | 108,950 | +5.3% | 0.03% | $169,962 |
| XTX Topco Ltd | 0.25% | 68,865 | +41% | 0% | $107,429 |
| UBS Group AG | 0.22% | 60,803 | -61% | 0% | $94,852 |
| Bank of New York Mellon Corp | 0.21% | 58,521 | -2.2% | 0% | $91,293 |
| GOLDMAN SACHS GROUP INC | 0.2% | 56,477 | +269% | 0% | $88,104 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.18% | 50,252 | +20% | 0% | $78,393 |
| Laird Norton Wetherby Trust Company, LLC | 0.16% | 45,000 | +80% | 0% | $70,200 |
| Jain Global LLC | 0.15% | 42,051 | 0% | $65,600 | |
| JPMORGAN CHASE & CO | 0.15% | 41,365 | -28% | 0% | $64,530 |
| Focus Partners Advisor Solutions, LLC | 0.15% | 41,097 | +0.36% | 0% | $64,111 |
| PNC Financial Services Group, Inc. | 0.14% | 37,805 | -1.5% | 0% | $58,976 |
| BARCLAYS PLC | 0.11% | 32,018 | +6.7% | 0% | $49,949 |
| RHUMBLINE ADVISERS | 0.1% | 27,527 | +22% | 0% | $42,935 |
| BANK OF MONTREAL /CAN/ | 0.09% | 25,987 | 0% | $40,540 | |
| TWO SIGMA SECURITIES, LLC | 0.09% | 25,363 | 0.01% | $39,566 | |
| WELLS FARGO & COMPANY/MN | 0.09% | 24,857 | +79% | 0% | $38,777 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 5,083,640 | $7,930,834 | +$653,755 | $1.56 | 73 |
| 2025 Q3 | 4,655,922 | $9,636,676 | -$1,934,721 | $2.07 | 73 |
| 2025 Q2 | 5,623,690 | $12,725,267 | -$10,010,248 | $2.31 | 78 |
| 2025 Q1 | 6,162,475 | $48,114,521 | -$163,536 | $7.81 | 81 |
| 2024 Q4 | 6,324,914 | $29,538,643 | +$2,163,001 | $4.67 | 72 |
| 2024 Q3 | 5,352,153 | $28,834,750 | +$6,030,346 | $5.39 | 65 |
| 2024 Q2 | 4,566,933 | $40,279,815 | +$15,412,868 | $8.82 | 56 |
| 2024 Q1 | 2,738,821 | $32,179,382 | +$5,308,168 | $11.75 | 50 |
| 2023 Q4 | 2,292,004 | $25,807,938 | +$1,854,241 | $11.26 | 47 |
| 2023 Q3 | 2,133,529 | $14,477,326 | -$5,887,298 | $6.77 | 36 |
| 2023 Q2 | 2,186,070 | $24,850,986 | +$8,529,775 | $9.08 | 32 |
| 2023 Q1 | 1,804,387 | $11,657,371 | +$1,101,433 | $6.46 | 33 |
| 2022 Q4 | 1,645,407 | $10,430,707 | -$728,047 | $6.34 | 32 |
| 2022 Q3 | 1,912,551 | $11,855,780 | -$744,186 | $6.20 | 32 |
| 2022 Q2 | 2,010,894 | $17,633,536 | -$2,412,787 | $8.84 | 34 |
| 2022 Q1 | 2,294,234 | $19,315,368 | -$2,106,118 | $8.42 | 32 |
| 2021 Q4 | 2,484,556 | $25,343,080 | +$4,757,601 | $10.20 | 42 |
| 2021 Q3 | 1,942,445 | $37,703,608 | +$4,889,864 | $19.42 | 40 |
| 2021 Q2 | 1,710,752 | $30,053,028 | +$8,038,213 | $17.57 | 39 |
| 2021 Q1 | 1,305,763 | $15,492,692 | +$5,444,483 | $11.88 | 32 |
| 2020 Q4 | 793,136 | $13,655,776 | +$1,189,170 | $17.21 | 25 |
| 2020 Q3 | 992,741 | $10,252,248 | +$6,463,618 | $10.30 | 27 |
| 2020 Q2 | 358,561 | $1,881,000 | +$104,639 | $5.17 | 11 |
| 2020 Q1 | 342,213 | $1,139,000 | +$200,616 | $3.32 | 9 |
| 2019 Q4 | 282,367 | $1,637,000 | +$40,401 | $5.80 | 9 |
| 2019 Q3 | 274,538 | $1,620,000 | +$1,390,869 | $5.90 | 9 |
| 2019 Q2 | 38,466 | $373,000 | -$43,981 | $9.72 | 7 |
| 2019 Q1 | 45,117 | $352,000 | +$352,000 | $7.44 | 5 |